NCT05925725View on ClinicalTrials.gov

Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 25, 2023

Primary Completion Date

May 5, 2023

Study Completion Date

September 6, 2023

Conditions
Osteo Arthritis Knee
Interventions
DRUG

• harpagozid • boswellin = LOXACON

Exercise therapy

Trial Locations (1)

Unknown

Lakitelek foundation, Lakitelek

All Listed Sponsors
lead

Polyclinic of the Hospitaller Brothers of St. John of God, Budapest

OTHER